Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NEUP compared with PASG: revenue, margins and what each company keeps, and the suppliers and customers both name
NEUP
Neuphoria Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NEUP
Neuphoria Therapeutics Inc.
vs
PASG
Passage BIO, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NEUP
6
MRK
Merck
customer
—
Danforth Advisors
unlisted
supplier
—
Wolf & Company, P.C
unlisted
supplier
—
WG Partners LLP
unlisted
supplier
2 more · NEUP chain
›
Shared
0
No shared counterparties.
Only PASG
1
—
Gemma
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
NEUP
Neuphoria Therapeutics Inc.
Change
2.80
▲
+1.08%
· post 2.80
Mkt cap
$15.0M
Revenue
$15M
Q3 FY25
PASG
Passage BIO, Inc.
Change
3.90
▲
+12.72%
· post 3.94
Closed
Nov 6 '26
Mkt cap
$11.1M
Revenue
$99,000
Q3 FY24
vs
Compare
Closed
Nov 6 '26
NEUP
Neuphoria Therapeutics Inc.
vs
PASG
Passage BIO, Inc.
2.80
▲
+1.08%
post 2.80
Price
3.90
▲
+12.72%
post 3.94
$15.0M
Mkt cap
$11.1M
Q3 FY25
$15M
Revenue
$99,000
Q3 FY24
Change
Change
NEUP
2.80
▲
+1.08%
vs
PASG
3.90
▲
+12.72%
Closed
Nov 6 '26